Western diet as a trigger of Alzheimer’s disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration

[Display omitted] •Western diet (WD) can accelerate and enhance inflammaging and induction of Alzheimer’s disease (AD).•WD-induced obesity, metabolic disorders and gut microbiota dysbiosis can lead to AD.•WD-induced metabolic and systemic inflammation impair blood-brain barrier.•WD drives neuroinfla...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ageing research reviews 2021-09, Vol.70, p.101397, Article 101397
Hauptverfasser: Więckowska-Gacek, Angelika, Mietelska-Porowska, Anna, Wydrych, Małgorzata, Wojda, Urszula
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •Western diet (WD) can accelerate and enhance inflammaging and induction of Alzheimer’s disease (AD).•WD-induced obesity, metabolic disorders and gut microbiota dysbiosis can lead to AD.•WD-induced metabolic and systemic inflammation impair blood-brain barrier.•WD drives neuroinflammation, amyloid and tau pathology, and memory impairment.•Dietary manipulations hold promise for AD prevention and support in therapy. An excess of saturated fatty acids and simple sugars in the diet is a known environmental risk factor of Alzheimer's disease (AD) but the holistic view of the interacting processes through which such diet may contribute to AD pathogenesis is missing. We addressed this need through extensive analysis of published studies investigating the effects of western diet (WD) on AD development in humans and laboratory animals. We reviewed WD-induced systemic alterations comprising metabolic changes, induction of obesity and adipose tissue inflammation, gut microbiota dysbiosis and acceleration of systemic low-grade inflammation. Next we provide an overview of the evidence demonstrating that WD-associated systemic alterations drive impairment of the blood-brain barrier (BBB) and development of neuroinflammation paralleled by accumulation of toxic amyloid. Later these changes are followed by dysfunction of synaptic transmission, neurodegeneration and finally memory and cognitive impairment. We conclude that WD can trigger AD by acceleration of inflammaging, and that BBB impairment induced by metabolic and systemic inflammation play the central role in this process. Moreover, the concurrence of neuroinflammation and Aβ dyshomeostasis, which by reciprocal interactions drive the vicious cycle of neurodegeneration, contradicts Aβ as the primary trigger of AD. Given that in 2019 the World Health Organization recommended focusing on modifiable risk factors in AD prevention, this overview of the sequential, complex pathomechanisms initiated by WD, which can lead from peripheral disturbances to neurodegeneration, can support future prevention strategies.
ISSN:1568-1637
1872-9649
DOI:10.1016/j.arr.2021.101397